Literature DB >> 16275963

Applying the 2005 Canadian Hypertension Education Program recommendations: 5. Therapy for patients with hypertension and diabetes mellitus.

Sheldon Tobe1, Finlay A McAlister, Lawrence Leiter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16275963      PMCID： PMC1277040          DOI： 10.1503/cmaj.050188

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

Authors:  M Ravid; D Brosh; D Ravid-Safran; Z Levy; R Rachmani
Journal:  Arch Intern Med       Date:  1998-05-11

2.  The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Authors:  Nadia A Khan; Finlay A McAlister; Richard Z Lewanczuk; Rhian M Touyz; Raj Padwal; Simon W Rabkin; Lawrence A Leiter; Marcel Lebel; Carol Herbert; Ernesto L Schiffrin; Robert J Herman; Pavel Hamet; George Fodor; George Carruthers; Bruce Culleton; Jacques DeChamplain; George Pylypchuk; Alexander G Logan; Norm Gledhill; Robert Petrella; Norman R C Campbell; Malcolm Arnold; Gordon Moe; Micharl D Hill; Charlotte Jones; Pierre Larochelle; Richard I Ogilvie; Sheldon Tobe; Robyn Houlden; Ellen Burgess; Ross D Feldman
Journal:  Can J Cardiol       Date:  2005-06       Impact factor: 5.223

3.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

4.  The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability.

Authors:  L Hansson; A Zanchetti
Journal:  Blood Press       Date:  1997-09       Impact factor: 2.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.